Efficacy and Safety Study of Fentanyl Transdermal Patch for Treatment of Chronic Pain
CompletedPhase 4NCT01902524
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to confirm effectiveness and safety of fentanyl transdermal patch Durogesic® D-Trans for treatment of chronic pain in participants with chronic non-cancer pain.
Study details
- Official title
- Evaluation in Efficacy and Safety of Fentanyl-TTS (Durogesic® D-Trans) for Treatment of Chronic Pain
- Conditions
- Interventions
- Drug: Fentanyl-TTS
- Sponsor
- Janssen Korea, Ltd., Korea
- Start date
- 2005-10
- Primary completion
- 2006-11
- Sex
- All
- Age range
- from 19 Years
- Results posted
- No results posted in this snapshot
- Countries
- South Korea
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * spine related and extremity pain lasting for 3 months or longer * pain with Numeric Rating Scale (NRS) at 4 or higher in the past 72 hours * good overall health condition based on the medical history and clinical laboratory tests * participants using appropriate contraception in case of childbearing potential during the study period. Exclusion Criteria: * history of hypersensitive reaction to narcotic analgesics * history of narcotic abuse * serious psychotic disorder * unable to use transdermal analgesics due to a dermatological condition * history of CO2 retention (e.g., chronic obstructive pulmonary disease) * surgery in the area with pain within 7 days prior to initiation of the clinical study.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01902524